Adobe stock photos - DARIKAFinancingSofinnova Partners closes €165m Biovelocita II biotech acceleration fundSofinnova Partners has raised €165m within its biotech acceleration fund Biovelocita II that attracted investments fromBig Pharma including Amgen, Bristol Myers Squibb, and Pfizer Ventures. more ➔
Polish Ministry of Agriculture - MRiRWNGTPoland breaks opposition to EU NGT deregulationAt the third attempt, the Polish Council Presidency has broken the resistance of the member states against the deregulation of crops produced by new genomic technologies (NGT). The new draft will enter … more ➔
SpliceBioGene therapySpliceBio lauches Phase I/II study on dual-AAV-based therapy for Stargardt DiseaseSpanish SpliceBio has dosed the first patient with SB-007, the first dual AAV gene therapy in clinical development for Stargardt disease more ➔
FSA UKCell-based meatRegulatory sandbox will speed up safety assessment of cell-based foodThe UK Food Standards Agency (FSA) has selected eight companies to participate in a two-year regulatory programme set to speed up market approval and safety assessment of cell-cultivated products. more ➔
asobe stock photos - catalin ObesityRoche inks US$1.65bn obesity deal with Zealand PharmaRoche is extending its obesity pipeline signing a US$5.3bn biobucks deal with Zealand Pharma A/S, who will co-develop and co-commercialise a monotherapy of its long-acting amylin analogue petrelintide … more ➔
Adobe stock - maurice norbert ObesityNovo Nordisk’s obesity drug CagriSema disappoints againNovo Nordisk A/S’ combined GLP1-, amylin- and calcitonin receptor agonist CagriSema has failed to meet the expected 25% weight loss within 68 weeks in the second of four pivotal Phase III trials. Shares … more ➔
Roche AGSLAS/AutomationRoche unveils completely new sequencing approachRoche researchers have introduced a greatly improved long-read nanopore sequencing method that has the potential to erase the sequencing-by-synthesis approach of market leader Illumina. more ➔
Hummingbird BioscienceFinancingADC maker Callio Therapeutics secures US$187m in Series A roundInvestment company Frazier Life Sciences has launched the virtual ADC company Callio Therapeutics Inc by licencing Hummingbird Bioscience’s TopDDRive dual payload ADC technology and co-leading a US$187m … more ➔
Audiovisual Library of the European CommissionEU CommissionEU Commission presents Clean Industrial DealThe European Commission has presented its long-awaited Clean Industrial Deal, which aims at replacing its Green Deal in times of geopolitical tensions, slow economic growth and technological competition … more ➔
Fuse VectorsPre-seed FinancingGene therapy manufacturing: Fuse Vectors secures US$5.2mFuse Vectors has secured US$5.2m in pre-seed financing to revolutionise gene therapy manufacturing with its cell-free viral vector technology. The Danish company is aiming to make treatments more accessible … more ➔